PMID: 15218391Jun 26, 2004Paper

Hypertensive heart disease and fibrosis

Current Opinion in Cardiology
Joanne MoncrieffFrancis G Dunn

Abstract

The clinical importance of fibrosis in hypertensive heart disease is now well recognized. However, the precise mechanisms involved in the pathophysiology and therefore the potential cardioreparative strategies are still not fully understood. These areas continue to be the focus of extensive research. This review summarizes the work conducted in this field over the past 12 months. This article further confirms the involvement of the renin-angiotensin system in cardiac fibrosis and illustrates the supportive roles of mineralocorticoids, endothelin, and novel signaling pathways. It also summarizes the most recent data examining the genetic aspects of myocardial fibrosis and further clarifies potential cardioreparative strategies. Myocardial fibrosis in hypertensive heart disease remains an area of intensive research. Whereas recent work has expanded our knowledge of the underlying processes in the development of this fibrosis, additional scientific and clinical research is required to assist clinical risk assessment and to provide evidence that therapeutic intervention confers improved clinical outcome in hypertensive heart disease.

References

Sep 1, 1994·Cardiovascular Research·Y SunK T Weber
Feb 9, 1996·The Journal of Biological Chemistry·T YamazakiY Yazaki
Nov 1, 1996·Hypertension·J MayetS A Thom
May 1, 1997·Journal of Molecular and Cellular Cardiology·L C KatwaK T Weber
Oct 28, 1999·Cardiovascular Research·G P RossiA C Pessina
Feb 13, 2001·American Journal of Physiology. Heart and Circulatory Physiology·K KusumotoM Karmazyn
Mar 30, 2002·Cardiovascular Research·María C Camilión de HurtadoHoracio E Cingolani
Aug 3, 2002·Hypertension·M Mitchell LindsayFrancis G Dunn
Feb 8, 2003·Hypertension·Horacio E CingolaniMaría C Camilión de Hurtado
Feb 25, 2003·Journal of the American College of Cardiology·Teresa M SecciaGian Paolo Rossi
Mar 8, 2003·Hypertension·Fumitaka KuwaharaTsutomu Imaizumi
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Jul 23, 2003·Journal of Hypertension·Yong JiAlbert Ferro
Aug 7, 2003·Nephron. Physiology·Anette Fiebeler, Hermann Haller
Oct 29, 2003·Hypertension·Hongmei PengNour-Eddine Rhaleb
Apr 27, 2004·Journal of Hypertension·Karl T Weber

❮ Previous
Next ❯

Citations

Dec 7, 2006·Current Hypertension Reports·Kevin A Courville, Hector Ventura
Feb 8, 2011·Current Hypertension Reports·Krishna K GaddamCarl J Lavie
Dec 2, 2008·Acta Physiologica·A DanielsF A van Nieuwenhoven
Sep 3, 2008·The International Journal of Cardiovascular Imaging·Arnoud van der Laarse, Ernst E van der Wall
Apr 4, 2009·Der Internist·M Steinmetz, G Nickenig
Jul 20, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Jian FangPei-Qing Liu
May 12, 2009·The Medical Clinics of North America·Krishna K GaddamHector Ventura
Apr 26, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Fatiha BouzeghraneGaétan Thibault
Jun 16, 2005·Current Opinion in Cardiology·Jason A MitchellMandeep R Mehra
Jan 18, 2006·The Journal of Biological Chemistry·Ayanna S AugustusIra J Goldberg
Mar 28, 2008·Current Hypertension Reports·Jee Lee, Ira J Goldberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.